TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
7.66
-0.13 (-1.67%)
At close: Jun 25, 2025, 4:00 PM
7.41
-0.25 (-3.26%)
Pre-market: Jun 26, 2025, 6:34 AM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $6.39 million as of June 26, 2025. Its market cap has decreased by -12.33% in one year.
Market Cap
6.39M
Enterprise Value
-5.18M
1-Year Change
-12.33%
Ranking
Category
Stock Price
$7.66
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $6.39M, a decrease of -86.66%. That is a compound annual growth rate of -39.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 6.39M | 172.15% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.41B |
| Johnson & Johnson | 367.19B |
| AbbVie | 327.44B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 273.95B |
| Abbott Laboratories | 238.69B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |